Cell adhesion to endothelium regulates the trafficking and recruitment of leukocytes towards lymphoid organs and sites of inflammation. This phenomenon is mediated by the expression of a number of adhesion molecules on both the endothelium and circulating cells. Activation of endothelial cells (EC) with different stimuli induces the expression of several adhesion molecules (E-and P-selectins, ICAM-1, VCAM-1), involved in their interaction with circulating cells. In this report, we have studied the binding of nonactivated and activated B cells to purified E-and P-selectins. Activated but not resting B cells were able to interact with both selectins. This binding capacity of activated B cells paralleled the induction of different carbohydrate epitopes (Lewis', sialyl-Lewis', CD57 and CDw65) as well as other molecules bearing these or related epitopes in myeloid cells (L-selectin, aLfi2 and a Xfi2 integrins, and CD35) involved in the interaction of different cell types with selectins. B cells infiltrating inflamed tissues like in Hashimoto's thyroiditis, also expressed these selectin-binding carbohydrates in parallel with the expression of E-selectin by surrounding follicular dendritic cells. Moreover, the crosslinking of these selectin-binding epitopes resulted in an increased binding of B cells to different integrin ligands. Thus, in addition to the involvement of integrins, E-and P-selectins could play an important role in the interaction of B lymphocytes with the endothelium during B cell extravasation into lymphoid tissues and inflammatory foci as well as in their organization into lymphoid organs. (J. Clin. Invest. 1994. 94:1585-1596 
Introduction
Leukocyte interaction with the endothelium is a critical step in inflammatory and immune responses that is mediated by differ- 1 . Abbreviations used in this paper: CLA, cutaneous lymphocyte antigen; EC, endothelial cell(s); ECM, extracellular matrix; FDC, follicular dendritic cell(s); FN38, 38-kD proteolytic fibronectin fragment; GC: germinal center(s); ICAM, intercellular adhesion molecule; Lea, Lewisa; Le', Lewisx; sLea, sialyl-Lewisa; sLex, sialyl-Lewisx; VCAM, vascular cell adhesion molecule. ent adhesion molecules on both leukocytes and endothelial cells (EC)' (1, 2) . Two major groups of adhesive ligands have been described on EC: members of the Ig superfamily (ICAM-1, ICAM-2, VCAM-1, MAdCAM-1) and selectins (E-and P-selectins). On the other hand, leukocytes express different integrins and carbohydrate determinants interacting with endothelial Ig members and selectins, respectively (1) (2) (3) (4) (5) . Cell activation by different stimuli increases leukocyte binding to EC by acting on both sides: inducing the expression of ICAM-1, VCAM-1, and E-and P-selectins on EC and increasing the avidity of leukocyte integrins for their ligands ( [1] [2] [3] [4] [5] ). Adhesion of neutrophils to EC and migration into tissues involve, in subsequent steps, selectins and integrins (3) (4) (5) . While the initial attachment is mediated by the interaction of selectins with different carbohydrate determinants, the tight binding involves protein-protein interactions between functional activated ,62 integrins on neutrophils and members of the Ig superfamily on activated EC (3) (4) (5) (6) (7) .
The selectin family (CD62E, P, L), comprising the two vascular E-and P-selectins and the leukocyte L-selectin, has been involved in leukocyte migration to sites of inflammation and entry into lymphoid organs (8) . All three selectins bind to a similar, but not identical, set of glycosylated determinants (8) (9) (10) . Thus, L-, E-and P-selectins recognize terminally a(2,3) sialylated forms of a(1,3) and a(1,4) fucosylated lactosaminoglycans such as sialyl-Lewisx (sLex, CD15s) and sialylLewisa (sLea), respectively (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . These epitopes decorate a number of glycoproteins and glycolipids (e.g., the L-selectin [21, 22] and CD66 [23] ). In addition, E-selectin binds to the glycosylated cutaneous lymphoid antigen (CLA, HECA-452 antigen) expressed by T cells with hallmarks of skin homing ( 16, 24, 25 ) , as well as to the CDw65 epitope present on surface expressed glycolipids on neutrophils (26, 27) . On the other hand, P-selectin recognizes the nonsialylated LewisX (Lex, CD15) (28) and certain sulfated and polyanionic polysaccharides (29, 30) . L-selectin also interacts with sulfated and phosphomannan polysaccharides (8) .
Regarding lymphocyte interaction with E-and P-selectins, albeit at much lower levels than neutrophils, NK cells, certain minor T cell subsets and chronically activated T cells, as those infiltrating chronic inflammatory sites, also interact with both selectins (31) (32) (33) (34) (35) (36) (37) (38) (39) .
Early studies documented the existence of a different pattern of migration to lymphoid organs by B and T cells and that this pattern could be altered during cellular activation (40) . To that effect, B cell activation increases the expression of several integrins that mediate binding to EC (aL,62 [ (41) (42) (43) (44) . To 
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In double immunostaining, after the development of the DAB reaction, the sections were saturated with nonspecific mouse 1g, washed and then incubated with the second mAb in the same conditions. Subsequently, they were incubated with a rabbit anti-mouse IgG coupled to alkaline phosphatase (Dakopatts). Finally, the alkaline phosphatase reaction was developed by incubating the sections with a solution of 0.2 mg/ml of Naphtol AS-MX phosphate, 1 mg/ml of fast-blue salt and l0-5 M Levamisole (all from Sigma Chemical Co) dissolved in 50 mM Tris COH, pH 8.4. The reaction gives a bright blue precipitate that contrasts with the brown color of the DAB reaction. Each section was examined under scope by at least two different expert observers.
Results
Binding of activated B lymphocytes to E-and P-selectins. To study whether activated B cells bind to endothelial members of the selectin family, we examined their attachment to recombinant E-selectin and purified P-selectin. Tonsillar B cells activated for two days with the phorbol ester PMA (5 ng/ml) attached to E-and P-selectins whereas nonactivated B cells did not (Fig. 1) . B cell binding to E-selectin was specifically inhibited by anti-E-selectin BB mAb but not by anti-P-selectin GI and S12 mAbs ( Fig. 1 A) . Conversely, cell binding to Pselectin was selectively blocked by Gl mAb but not by BB I1 mAb and the nonblocking anti-P-selectin S 12 mAb (Fig. 1 B) . B cell binding to E-and P-selectins was also inhibited in the presence of 5 mM EDTA (Fig. 1) . No significant binding to type I collagen was observed in any activation state (Fig. 1) .
B cell activation induces the expression of carbohydrate determinants implicated in cell binding to selecting. The capacity of activated B cells to interact with both endothelial selecting, prompted us to explore the expression by B cells of the determinants responsible for such interactions. Cells recognize E-and P-selectins through different carbohydrate epitopes (for reviews see references 8 and 10). Thus, while LeX and sLeX are expressed by the great majority of monocytes and neutrophils, sLea has only been described on epithelial tumor cells. sLeX is also expressed by a small fraction (-5-15%) of circulating T lymphocytes (24, 49) . Using a wide panel of mAbs, we studied the expression of these and related carbohydrate determinants on activated and nonactivated B cells (Fig. 2) . Lex, sLeX and sLea were barely expressed or absent on nonactivated B cells (Fig. 2) . Activation with phorbol esters induced the expression of both LeX and sLeX, but not sLea, that was evident by day 1 reaching the peak between 24 to 48 h. Afterwards, some downregulation of these epitopes was observed (data not shown). B cell activation also increased the expression of aL,62 and aX/2 integrins, CD35 and L-selectin (Fig. 2) . Interestingly, on neutrophils the Lex epitope decorates CD35 and 62 integrins (50), whereas the sLeX is modifying the L-selectin and CD66 antigens (21) (22) (23) Some authors have reported that E-selectin, but not P-selectin, interacts with internally sialylated fucosylated polylactosamines, such as the myeloid CDw65 antigen (26, 27) . B cell activation also led to an induced expression of CDw65, which was not detected on nonactivated B cells, as demonstrated by the reactivity with the anti-CDw65 VIM-2 mAb (Fig. 2) .
P-and L-selectins, but not E-selectin, also recognize sulfated polyanionic glycans including different glycosphingolipids as those recognized by the anti-CD57 HNK-1 mAb (51). Again, nonactivated B cells were negative for these sulfated glucuronyl ceramides, whereas activation induced the expression of this epitope (Fig. 2) . Although a good correlation between cell binding to P-selectin and reactivity with the Sulph I mAb, recognizing sulfatides, has been established (29), we were unable to detect expression of this epitope on either nonactivated or activated B cells (Fig. 2) . Although nonactivated B cells were not stained with HECA-452 mAb, activated B cells showed strong reactivity for this mAb (Fig. 2) . The HECA-452 mAb in addition to recognize CLA, also reacts with a common determinant on both sLeX and sLea antigens which may represent the glycosylated epitope recognized by E-selectin on these saccharides ( 16) . Therefore, we investigated whether B cell reactivity with HECA-452 mAb was due to the recognition of the sLeX determinant or to the presence of the CLA antigen on B lymphocytes. Double labeling with HECA-452 and CSLEX-1 mAbs showed that the majority of activated B cells react with both mAbs and, contrary to that observed in T lymphocytes (24, 52) , no B cell subsets expressing distinctively any determinant could be distinguished (Fig.  3 A) . To ascertain whether HECA-452 reactivity was related with the expression of the 200-kD CLA glycoprotein(s) described on T cells (45, 52) , Western blot analyses were performed. As shown in Fig. 3 B, HECA-452 mAb reacted on B cells with proteins at the level of 200 kD similarly to that observed in tonsillar T cells (Fig. 3 B and reference 45) . Additional bands ranging from 50 to 180 kD were also observed, probably reflecting sLeX reactivity as described in other cell types ( Fig. 3 B and reference 45) . Bands -130 kD were found in lysates from U937 cells (Fig. 3 B and reference 45) .
Taken together, these results indicate that whereas most selectin-binding carbohydrates were virtually absent on nonacti- Carbohydrate determinants involved in B cell binding to Eand P-selectins. To ascertain which carbohydrate epitopes from those induced upon activation were implicated in B cell binding to E-and P-selectins, adhesion assays to both selectins were performed in the presence of different mAbs (Figs. 4 and 5) . CSLEX-1 mAb, against the sialylated form of Lex, inhibited B cell binding to E-selectin (Fig. 4) . A similar blocking effect was found with the HECA-452 mAb. However, anti-sLea lHlO, anti-CDw65 VIM-2 and anti-CD57 HNK-1 mAbs did not significantly affect B cell attachment to E-selectin (Fig. 4) . The binding of activated B lymphocytes to P-selectin was We investigated whether any of these FucTs was induced during B cell activation by Northern blot analyses using specific probes for FucT-III to -VI (Fig. 6) . Cellular FucT-III (Lewis Figure 5 . FucT) and -IV (myeloid FucT) were detected on epithelial A43 1 cells and myeloid U937 and HL60 cells, respectively, but not on activated B cells (Fig. 6, A and B) . On the other hand, we detected FucT-V and -VI transcripts on hepatoma HepG2 and epidermoid A431 cells but not on activated B cells (Fig.  6, C and D) .
These results show that any of the thus far cloned FucTs are expressed, or at least at significant levels, on B lymphocytes, thus suggesting that a new Fuc-T(s) would be responsible for the synthesis of these carbohydrate epitopes in B cells.
Crosslinking of the selectin-binding epitopes increased B cell attachment to fibronectin and ICAM-1. Adhesion of circulating cells to the endothelium, ulterior extravasation and interaction with subendothelial extracellular matrix components (ECM) result from the sequential and cooperative participation of selectins and integrins (3) (4) (5) . We sought whether B cell interaction with selectins could regulate further attachment to endothelium and ECM through /31 and 62 integrins. To this effect, we crosslinked the sLex and HECA-452 epitopes on two B cell lines, WIL2-NS and GUS, expressing most selectinbinding carbohydrates and studied their a4-and aL,32-integrinmediated interactions with a fibronectin fragment (FN38) and VCAM-1 as well as with a recombinant form of ICAM-1, respectively ( Fig. 7 and not shown) . Incubation of WIL2-NS and GUS cells with CSLEX-1 and HECA-452 mAbs, followed by specific anti-mouse or anti-rat IgM antibodies resulted in an increased cell binding to FN38 and VCAM-1 whereas no effect was observed with control matched isotype mAbs (Fig. 7 and data not shown) . integrins, respectively, as concluded from the specific inhibitory effect exerted by anti-a4 and anti-f32 mAbs (data not shown) (44) . Moreover, enhanced binding to these ligands upon crosslinking of these glycosylated epitopes was not accompanied by changes in the expression of a4, aL or ,B1 integrins (data not shown), reflecting that a conformational change in a4 and L,B2
integrins is likely accounting for these increased binding capacities.
The expression of selectin-binding epitopes on B cells infiltrating inflamed tissues parallels the expression of E-selectin onfollicular dendritic cells. To elucidate whether the expression of these glycosylated epitopes and the binding to vascular selectins by in vitro activated B cells, could be a mechanism regulating B cell interactions in vivo, we examined the expression of these adhesion molecules in diseases where B (Fig. 8 A) , as evidenced by parallel staining with the FDC-specific DRC-l mAb (Fig. 8 B) and by double staining with both mAbs (data not shown). A positive staining for LeX, sLeX, and HECA-452 epitopes was found in GC on both mononuclear cells and FDC (Fig. 8, C-E) . The expression of these saccharides by B cells was confirmed by parallel staining with the B cell-specific anti-CD20 B1 mAb (Fig. 8 F) , as well as by double staining for anti-HECA-452 (peroxidase) and anti-CD20 (alkaline phosphatase) mAbs (Fig.  8 G) . Double staining for anti-DRC-1 and anti-HECA-452 mAbs demonstrated the expression of these saccharides also by FDC (Fig. 8 H) (45) .
Discussion
The Despite the concomitant expression by activated B cells of all the selectin-binding epitopes described on myeloid-, T-and NK-cell adhesion to selecting, only CSLEX-1 and HECA-452 mAbs were able to inhibit B cell binding to E-and P-selectins. Although the inhibitory effect by these mAbs is almost complete, the existence of additional epitopes involved in these interactions can not be ruled out. To thas, effect, bovine y/6 T cells, lacking sLeX and CLA expression, are able to interact with E-selectin (36) , suggesting the existence of new E-selectin-binding determinants in this T cell subset. In myeloid cells, LeX and sLe' epitopes are decorating different glycoproteins such as the L-selectin (21, 22) , #32 integrins (50) , CD35 (50) , and the CEA-related CD66 antigen (23) . Interestingly, during B cell activation, parallely to the induction of LeX and sLeX, a severalfold increase in the expression of L-selectin, CD35 and aL/32 integrin and the induction of aXB2 integrin was observed. Although it has been described the involvement of CDw65 and LeX antigens in neutrophil binding to E-and Pselectins, respectively (26, 27) , we were unable to find any effect of these mAbs in agreement with other reports questioning the involvement of both epitopes in cell binding to vascular selectins (15, 56, 57) . As expected from the lack of effect of Lex mAbs on B cell binding to E-and P-selectins, mAbs blocking CD35 and /2 interactions had not inhibitory effect either. The failure of anti-L-selectin mAbs to block B cell interaction with E-and P-selectins could be attributed to a differential processing of L-selectin in myeloid and B cells as previously reported for T cells (22) .
Sulfatides and certain sulfated glycans are involved in myeloid and tumor cell binding to P-selectin (29, 30) , but their mechanism of action is not yet clear (20, 30) . Even though some sulfated saccharides partially inhibit B cell binding to Pselectin (A. A. Postigo, unpublished results), activated B cells do not react with the anti-sulfatide s Sulph I mAb. Although reactivity with this mAb has been strictly correlated with binding to P-selectin (29) , other cell types binding to this selectin such as the neuroblastoma cell line NK-N-SH (60) as well as NK cells (37) , lack reactivity for Sulph I mAb (A. A. Postigo, unpublished observations).
The expression of the different sialylated fucosylated saccharides by activated B cells is not accompanied by the induction of FucT-I1I to -VI, suggesting that a new FucT(s) to be identified would be responsible of the synthesis of these epitopes in B cells. To this effect, studies from Lowe's group indicate the existence of new FucTs different to those heretofore cloned (57) . It is worth to remark that B cells show certain restricted glycosyltransferase activities. Thus, a(2,6) sialyltransferase (ST) is involved in the modification of different proteins including CDw75, CDw76 and HB6 antigens (61, 62) , some of them, like the CDw75, almost limited to B cells (61) . Some of these a( 2,6) sialic epitopes are ligands for the B cell-restricted CD22P antigen and are involved in cell-cell adhesions (62), although they would not participate in B cell adhesion to selectins since the addition of these residues prevent the action of a( 1,3) FucTs and the generation of sLex. Thus, the generation of a(2,3) and a (2, 6) (65) . In the angiofollicular lymph node hyperplasia (Castleman's disease), a typical B cell disorder with abnormal GC organization and attributed to a chronic stimulation of B cells, an aberrant expression of Eselectin was detected on FDC and also on some giant cells contacting with B lymphocytes (66) . Thus, it is tempting to speculate that in these and other processes, selectin-mediated adhesions could play a role in the interaction between B cells and FDC and interfering somehow B cell function. In that sense, the interaction of a401 and aL,62 on B cells with VCAM-1 and ICAM-1 on FDC, respectively, has been suggested to be involved in several GC B cell functions and in the formation of the GC itself (67, 68) .
Cell activation regulates not only the expression of the different adhesion molecules but also their ligand affinity (1, 2) . Thus, it is largely reported that crosslinking of different cell surface glycoproteins upregulates integrin function by an still undefined conformational change(s) (1, 2) . Our data demonstrate that crosslinking of these selectin-binding epitopes also increases B cell binding to FN38, VCAM-1, and ICAM-l without changes in a4 and aL/32 integrin expression, reflecting a conformational change in these integrins probably secondary to signaling through these carbohydrates. In that sense, the engagement of sLex on myeloid cells induces calcium mobilization and oxidative burst (69) . Moreover, crosslinking of LeX on neutrophils also increases adhesion to ICAM-1 although an increased expression of the aL/62 integrin is accounting for this effect (70) . Recent models on leukocyte interaction with EC implicate selectins and integrins in subsequent and cooperative steps (3) (4) (5) (6) (7) . Thus, from our data it could be hypothesized that adhesion of sLex-positive B cells to E-and P-selectins would trigger intracellular signaling enhancing cell binding to endothelial Ig members and posterior extravasation and interaction with ECM. In this regard, neutrophil adhesion to E-selectin enhances the avidity of aM,/2 integrin for C3bi (7) . Although an inhibitory effect has been reported for neutrophil interactions with Pselectin (71), a recent work described an indirect stimulatory effect of P-selectin facilitating neutrophil interaction with endothelial PAF (72).
In conclusion, these results extend our knowledge about B cell adhesion mechanisms indicating an interplay between integrin-and selectin-mediated 
